 |
|
|
| |
Ledipasvir/Sofosbuvir With Ribavirin in Patients With Decompensated Cirrhosis or Liver Transplantation and HCV Infection: SOLAR-1 and -2 Trials
|
| |
| |
Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
Edward Gane,1 Michael Manns,2 Geoffrey McCaughan,3 Michael P. Curry,4 Markus Peck-Radosavljevic,5 Hans Van Vlierberghe,6 Sarah Arterburn,7 Chohee Yun,7 Phillip S. Pang,7 Diana M. Brainard,7 John G. McHutchison,7 Princy Kumar,8 Eric Yoshida,9 Massimo Colombo,10 Bart van Hoek,11 Jean-François Dufour,12 Charles Landis,13 Robert Brown,14 David Mutimer,15 Steven L. Flamm,16 Mike Charlton,17 K. Rajender Reddy,18 Didier Samuel,19 Gregory T. Everson,20 Xavier Forns21
1The University of Auckland, New Zealand; 2Hannover Medical School, Hannover, Germany; 3Royal Prince Alfred Hospital, The University of Sydney, New South Wales, Australia; 4Beth Israel Deaconess Medical Center, Boston, MA; 5Medical University of Vienna, Austria; 6Universitair Ziekenhuis Gent, Belgium; 7Gilead Sciences, Inc., Foster City, CA; 8Georgetown University, Washington, DC; 9The University of British Columbia, Vancouver, Canada; 10The University of Milan, Italy; 11Leiden University, Leiden, the Netherlands; 12University of Bern, Switzerland; 13Harborview Medical Center, UW Medicine, Seattle, WA; 14Weill Cornell Medicine, New York, NY;
15Queen Elizabeth Hospital Birmingham, University of Birmingham, UK; 16Northwestern University Feinberg School of Medicine, Chicago, IL; 17Intermountain Medical Center, Murray, Utah; 18University of Pennsylvania School of Medicine, Philadelphia, PA; 19Université Paris-Sud, Villejuif, France; 20University of Colorado Anschutz Medical Campus, Aurora, CO; 21CIBEREhd, IDIBAPS, Hospital Clínic, Barcelona, Spain
|
| |
|
|
|
|
|
